Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

The nature, magnitude, and reporting compliance of device-related events for intravenous patient-controlled analgesia in the FDA Manufacturer and User Facility Device Experience (MAUDE) database.

Lawal OD, Mohanty M, Elder H, et al. The nature, magnitude, and reporting compliance of device-related events for intravenous patient-controlled analgesia in the FDA Manufacturer and User Facility Device Experience (MAUDE) database. Expert Opin Drug Saf. 2018;17(4):347-357. doi:10.1080/14740338.2018.1442431.

Save
Print Download PDF
July 18, 2018
Lawal OD, Mohanty M, Elder H, et al. Expert Opin Drug Saf. 2018;17(4):347-357.
View more articles from the same authors.

This study reviewed mandatory reporting of patient-controlled analgesia device-related events to the Food and Drug Administration postmarketing surveillance database. Less that 10% of reported events were deemed adverse events, and the vast majority of these were preventable. The authors call for development and adoption of patient-controlled analgesia devices with improved safety features and better training.

Save
Print Download PDF
Cite
Citation

Lawal OD, Mohanty M, Elder H, et al. The nature, magnitude, and reporting compliance of device-related events for intravenous patient-controlled analgesia in the FDA Manufacturer and User Facility Device Experience (MAUDE) database. Expert Opin Drug Saf. 2018;17(4):347-357. doi:10.1080/14740338.2018.1442431.